Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

CEA Industries Q3 EPS $(0.13), Sales $5.06M

CEA Industries (NASDAQ:CEAD) reported quarterly losses of $(0.13) per share. The company reported $5.06 million in sales this quarter.
byBenzinga Newsdesk
November 14, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

CEA Industries (NASDAQ:CEAD) reported quarterly losses of $(0.13) per share. The company reported $5.06 million in sales this quarter.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Best Buy Sees Q2 2023 Comp Sales -13%

By Benzinga Newsdesk
July 27, 4:19 PM
The company expects Q2 FY23 comparable sales1 to decline approximately 13%, with revenue approximately 7.5% higher than pre-pandemic Q2 FY20. This comparesThe company expects Q2 FY23 comparable sales1 to decline approximately 13%, with revenue approximately 7.5% higher than pre-pandemic Q2 FY20.

BBY

Read More

Ocular Therapeutix Announced Interim 7-month Data from U.S. Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet AMD; Said 80% of Subjects were Rescue-Free up to 6 months and 73% of Subjects Were Rescue-Free up to 7 months Following a Single OTX-…

By Charles Gross
September 27, 6:02 AM
Ocular Therapeutix, Inc. (NASDAQ: OCUL) today announced interim 7-month data from its U.S. Phase 1 clinical trial evaluating OTX-TKI, the Company's axitinib intravitreal hydrogel implant being developed for the treatment of wet age-related macular degeneration (wet AMD) and other retinal diseases.

OCUL